文献速递复苏、休克与脓毒症消化、代谢与肾脏急症

奥美拉唑通过抑制炎症介质提高两种大鼠脓毒症模型的生存率

Omeprazole Increases Survival Through the Inhibition of Inflammatory Mediaters in Two Rat Sepsis Models.
PubMed 文献 · Shock · 2022-01-01
一句话结论大鼠实验中奥美拉唑预处理可提高GalN/LPS与PH/LPS脓毒症模型生存率,并抑制TNF-α、iNOS、IL-6等炎症介质表达。

该研究在大鼠GalN/LPS肝损伤与70%肝切除(PH)/LPS两种脓毒症模型中,于造模前1小时给予奥美拉唑(OMZ),观察生存率、NF-κB活化、组织病理及炎症介质表达;体外用IL-1β刺激原代大鼠肝细胞并加或不加OMZ。结果显示OMZ提高两种模型生存率,降低肝内TNF-α、iNOS、CINC-1、IL-6、IL-1β mRNA并升高IL-10 mRNA;GalN/LPS组坏死与凋亡被抑制,PH/LPS组坏死无影响;OMZ部分通过抑制NF-κB信号抑制iNOS诱导。

要点

  • 在GalN/LPS与PH/LPS两种大鼠脓毒症模型中,造模前1小时给予OMZ均提高生存率。
  • OMZ降低两种模型肝内TNF-α、iNOS、CINC-1、IL-6、IL-1β mRNA表达,并升高IL-10 mRNA表达。
  • OMZ抑制GalN/LPS大鼠肝坏死与凋亡,但对PH/LPS大鼠坏死无影响。
  • 体外原代大鼠肝细胞中,OMZ部分通过抑制NF-κB信号抑制iNOS诱导。
  • 原文指出OMZ在两种模型中显示不同的剂量和机制。

适用人群与场景

  • LPS诱导肝损伤后D-半乳糖胺(GalN)处理的大鼠脓毒症模型
  • 70%肝切除(PH)后LPS处理的大鼠脓毒症模型
  • 体外原代培养大鼠肝细胞(IL-1β刺激)

处置流程与药物剂量

  • 两种体内模型中,OMZ于造模处理前1小时给药。
  • 体外模型中,原代培养大鼠肝细胞接受IL-1β刺激,并加或不加OMZ。

研究设计与关键结果

  • 研究类型:大鼠在体实验与体外原代肝细胞实验;人群:GalN/LPS与PH/LPS两种脓毒症大鼠模型及IL-1β刺激的原代大鼠肝细胞。
  • 干预与对照:造模前1小时给予OMZ,比较生存率、NF-κB活化、组织病理及肝与血清促炎介质表达;体外加或不加OMZ。
  • 主要终点:OMZ提高两种模型生存率,降低肝内TNF-α、iNOS、CINC-1、IL-6、IL-1β mRNA表达,升高IL-10 mRNA表达。
  • 组织病理:GalN/LPS大鼠中OMZ抑制坏死与凋亡;PH/LPS大鼠中OMZ对坏死无影响。
  • 机制:OMZ部分通过抑制NF-κB信号抑制肝细胞iNOS诱导。
  • 原文结论:OMZ抑制多种炎症介质诱导,从而预防GalN肝衰竭后及PH后LPS诱导的肝损伤,但两种模型所用剂量和机制不同。

证据类型、等级与局限

  • 证据类型:动物实验(大鼠在体模型)与体外细胞实验。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 原文未据此给出推荐。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Omeprazole (OMZ) is a proton pump inhibitor that is used to reduce gastric acid secretion, but little is known about its possible liver protective effects. This study investigated whether OMZ has beneficial effects in rat septic models of LPS-induced liver injury after D-galactosamine (GalN) treatment and 70% hepatectomy (PH), and to determine the mechanisms of OMZ in an in vitro model of liver injury.

METHODS: In the in vivo models, the effects of OMZ were examined 1 h before treatments in both models on survival, nuclear factor (NF)-κB activation, histopathological analysis, and proinflammatory mediator expression in the liver and serum. In the in vitro model, primary cultured rat hepatocytes were treated with IL-1β in the presence or absence of OMZ. The influence of OMZ on nitric oxide (NO) product and inducible NO synthase (iNOS) induction and on the associated signaling pathway was analyzed.

RESULTS: OMZ increased survival and decreased tumor necrosis factor-alpha, iNOS, cytokine-induced neutrophil chemoattractant 1, IL-6, and IL-1β mRNA expression, and increased IL-10 mRNA expression in the livers of both GaIN/LPS- and PH/LPS-treated rats. Necrosis and apoptosis were inhibited by OMZ in GaIN/LPS rats, but OMZ had no effects on necrosis in PH/LPS rats. OMZ inhibited iNOS induction partially through suppression of NF-κB signaling in hepatocytes.

CONCLUSIONS: OMZ inhibited the induction of several inflammatory mediators, resulting in the prevention of LPS-induced liver injury after GalN liver failure and PH, although OMZ showed different doses and mechanisms in the two models.

来源:Shock,查看原文。版权归原作者所有。

参考来源

  1. Kotsuka M, Hashimoto Y, Nakatake R, et al. Omeprazole Increases Survival Through the Inhibition of Inflammatory Mediaters in Two Rat Sepsis Models. Shock. 2022. PMID: 34923545. doi:10.1097/SHK.0000000000001897

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。